Stokes Capital Advisors LLC Has $6.84 Million Stake in Colgate-Palmolive (NYSE:CL)

Stokes Capital Advisors LLC trimmed its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 0.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 75,960 shares of the company’s stock after selling 170 shares during the quarter. Colgate-Palmolive makes up about 2.0% of Stokes Capital Advisors LLC’s investment portfolio, making the stock its 24th largest holding. Stokes Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $6,840,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Dark Forest Capital Management LP lifted its holdings in Colgate-Palmolive by 84.4% in the 3rd quarter. Dark Forest Capital Management LP now owns 9,002 shares of the company’s stock worth $640,000 after purchasing an additional 4,121 shares during the last quarter. Federated Hermes Inc. lifted its holdings in Colgate-Palmolive by 76.7% in the 3rd quarter. Federated Hermes Inc. now owns 43,703 shares of the company’s stock worth $3,108,000 after purchasing an additional 18,970 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after purchasing an additional 291 shares during the last quarter. Vinva Investment Management Ltd lifted its holdings in Colgate-Palmolive by 9.1% in the 3rd quarter. Vinva Investment Management Ltd now owns 37,534 shares of the company’s stock worth $2,677,000 after purchasing an additional 3,117 shares during the last quarter. Finally, Treasurer of the State of North Carolina lifted its holdings in Colgate-Palmolive by 0.4% in the 3rd quarter. Treasurer of the State of North Carolina now owns 371,243 shares of the company’s stock worth $26,399,000 after purchasing an additional 1,350 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CL. Stifel Nicolaus boosted their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, April 29th. The Goldman Sachs Group initiated coverage on Colgate-Palmolive in a research report on Friday, March 1st. They issued a “buy” rating and a $93.00 price objective for the company. Evercore ISI increased their price objective on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research report on Monday, April 8th. Bank of America increased their price objective on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, April 29th. Finally, Citigroup increased their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, April 16th. Three investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $93.83.

Get Our Latest Stock Analysis on Colgate-Palmolive

Insider Activity

In other news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the transaction, the insider now owns 3,181 shares in the company, valued at approximately $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock traded down $0.31 during mid-day trading on Friday, hitting $97.86. 462,892 shares of the company were exchanged, compared to its average volume of 4,421,439. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. The business has a fifty day moving average of $93.45 and a 200 day moving average of $87.30. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $99.08. The company has a market capitalization of $80.29 billion, a PE ratio of 31.07, a price-to-earnings-growth ratio of 3.62 and a beta of 0.39.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period in the prior year, the company posted $0.73 earnings per share. The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.04%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.